From the Department of Nuclear Medicine and Oncological Endocrinology, Maria Skłodowska-Curie Memorial District Hospital, Zgierz.
Clin Nucl Med. 2020 Dec;45(12):948-953. doi: 10.1097/RLU.0000000000003295.
Evaluation of utility of cervical ultrasound (US) for detection of thyroid remnants (ThR) in patients after thyroidectomy for differentiated thyroid cancer.
Included were 154 consecutive patients (17-89 years, 123 female and 31 male patients), without known cancer residues or cervical lymph nodes metastases, admitted for ThR ablation with I, 14 to 20 weeks after surgery. Neck uptake of I (Tup) and thyroglobulin were determined, and location and volume of ThR detected by cervical US were recorded. On days 3 to 4 after ablation (1.7-4.6GBq, 46-124.3 mCi I), neck SPECT/CT was performed, and I uptake foci were assigned to one of the regions as described below. The anterior neck was divided into 2 compartments: superior and inferior to lower margin of thyroid cartilage, and each compartment was subdivided into middle and lateral regions (in SPECT/CT, posterolateral and anterolateral regions were also marked out). I uptake sites and ThR detected by US, if congruent with SPECT/CT, were counted and analyzed.
In total, 341 I uptake foci were found in 150 patients (97.4%) by SPECT/CT and 213 corresponding ThR in 118 patients (76.6%) by US. Ultrasound detected 30% to 46% of I uptake foci in superior lateral regions, 49% in pyramidal lobe/thyroglossal duct area (both P < 0.05), 74% to 77% in inferior lateral regions, and 22% in isthmus (both P > 0.05). Correlation between ThR volume and Tup was strong (r = 0.79), and that between ThR volume and thyroglobulin was weak (r = 0.24).
Ultrasound is less sensitive than I posttherapy scans for ThR detection in patients after thyroidectomy, especially for remnants located above the lower margin of thyroid cartilage.
评估颈部超声(US)在分化型甲状腺癌患者甲状腺切除术后检测甲状腺残留(ThR)的效用。
纳入了 154 例连续患者(17-89 岁,123 名女性和 31 名男性患者),这些患者在手术后 14 至 20 周,无已知的癌症残留或颈部淋巴结转移,接受 I 进行 ThR 消融。测定颈部 I 摄取(Tup)和甲状腺球蛋白,并记录颈部 US 检测到的 ThR 的位置和体积。在消融后 3 至 4 天(1.7-4.6GBq,46-124.3mCi I)进行颈部 SPECT/CT,将 I 摄取灶分配到以下区域之一。前颈部分为 2 个区:甲状腺软骨下缘以上和以下,每个区再分为中间和外侧区(在 SPECT/CT 中,也标记出后外侧和前外侧区)。如果 SPECT/CT 与 US 检测到的 ThR 相吻合,则对 I 摄取灶和 ThR 进行计数和分析。
在 150 例患者(97.4%)的 SPECT/CT 中发现了 341 个 I 摄取灶,在 118 例患者(76.6%)的 US 中发现了 213 个相应的 ThR。US 检测到上外侧区 I 摄取灶的 30%至 46%,在舌骨下区/甲状舌管区的 49%(均 P <0.05),在下外侧区的 74%至 77%,以及峡部的 22%(均 P >0.05)。ThR 体积与 Tup 之间的相关性较强(r=0.79),而 ThR 体积与甲状腺球蛋白之间的相关性较弱(r=0.24)。
与 I 术后扫描相比,超声在甲状腺切除术后患者的 ThR 检测中敏感性较低,尤其是在下甲状腺软骨下缘以上的残留部位。